Imran Nazeer MD
Chronic Renal Failure & Dialysis, Hypertension, Interventional Nephrology
ETNA
Join to View Full Profile
409 Gaslight BlvdLufkin, TX 75904
Phone+1 936-634-2227
Fax+1 936-634-1470
Dr. Nazeer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Imran Nazeer is a nephrologist in Lufkin, TX and is affiliated with multiple hospitals in the area, including Woodland Heights Medical Center, Nacogdoches Medical Center, CHI St. Luke's Health Memorial Lufkin, Nacogdoches Memorial Hospital, CHI St. Luke's Health Memorial Livingston, CHI St. Luke's Health Memorial Specialty Hospital, and CHI St. Luke's Health Memorial San Augustine. He received his medical degree from King Edward Medical University and has been in practice 32 years. He also speaks multiple languages, including Hindi and Urdu. He specializes in chronic renal failure & dialysis, hypertension, and interventional nephrology and is experienced in hypertension, interventional nephrology, dialysis, continuous renal replacement therapy, and peritoneal dialysis.
Education & Training
University of MinnesotaFellowship, Nephrology, 1994 - 1996
Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1992 - 1994- Royal College of PhysiciansMRCP, Medicine, 1990 - 1991
King Edward Medical UniversityClass of 1985
Certifications & Licensure
TX State Medical License 1996 - 2026
SC State Medical License 2010 - 2010
MN State Medical License 1994 - 1997
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2011-2012
Clinical Trials
- Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects with Hypertension and Chronic Kidney Disease (CKD) with Albuminuria Start of enrollment: 2023 Dec 14
Roles: Contact
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
